- Previous Close
0.3300 - Open
0.3300 - Bid 0.3250 x --
- Ask 0.3300 x --
- Day's Range
0.3300 - 0.3300 - 52 Week Range
0.2900 - 0.5500 - Volume
803 - Avg. Volume
52,153 - Market Cap (intraday)
38.126M - Beta (5Y Monthly) -0.47
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical and natural health products in Canada. It offers dietary supplements and vitamins in the tablet and capsule form; and niche sterile ophthalmic products in the form of ointments and drops for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.
www.groupelslpharma.com114
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: LSL.V
View MorePerformance Overview: LSL.V
Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LSL.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LSL.V
View MoreValuation Measures
Market Cap
38.13M
Enterprise Value
52.00M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.98
Price/Book (mrq)
1.87
Enterprise Value/Revenue
3.29
Enterprise Value/EBITDA
109.02
Financial Highlights
Profitability and Income Statement
Profit Margin
-15.50%
Return on Assets (ttm)
-1.16%
Return on Equity (ttm)
-16.28%
Revenue (ttm)
15.82M
Net Income Avi to Common (ttm)
-2.45M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
164k
Total Debt/Equity (mrq)
68.94%
Levered Free Cash Flow (ttm)
-9.66M